Can Endothelin-1 Help Address the Diagnostic and Prognostic Challenges in Multimorbid Acute Heart Failure Patients?

Can Endothelin-1 Help Address the Diagnostic and Prognostic Challenges in Multimorbid Acute Heart Failure Patients?

The management of acute heart failure (AHF) is becoming increasingly complex, especially in patients with multiple comorbidities. Endothelin-1 (ET-1), a vasoconstrictive peptide, is an important mediator of neurohormonal activation, endothelial dysfunction, and cardiac remodeling—key processes invol...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bianca-Ana Dmour, Minerva Codruta Badescu, Cristina Tuchiluș, Corina Maria Cianga, Daniela Constantinescu, Nicoleta Dima, Ștefania Teodora Duca, Awad Dmour, Alexandru Dan Costache, Maria-Ruxandra Cepoi, Adrian Crișan, Sabina Andreea Leancă, Cătălin Loghin, Ionela-Lăcrămioara Șerban, Irina Iuliana Costache-Enache
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Life
Subjects:	endothelin-1 acute heart failure biomarker diagnosis prognosis multimorbidity
Online Access:	https://www.mdpi.com/2075-1729/15/4/628
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beyond a Single Marker: An Update on the Comprehensive Evaluation of Right Ventricular Dysfunction in Pulmonary Thromboembolism
by: Sandu Cucută, et al.
Published: (2025-04-01)

From Joints to the Heart: An Integrated Perspective on Systemic Inflammation
by: Diana Elena Cosău, et al.
Published: (2025-04-01)

THE ROLE OF ENDOTHELIN-1 IN VASCULAR HEMOSTASIS OF PERIODONTAL TISSUES
by: N.V. Yarychkivska
Published: (2018-03-01)

The role of endothelin receptor antagonists in kidney disease
by: Xiaoting Ma, et al.
Published: (2025-12-01)

Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis
by: K. Melissa Hallow, et al.
Published: (2024-11-01)

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
by: Michael P Smith, et al.
Published: (2017-06-01)

Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)
by: Qingjian He, et al.
Published: (2025-01-01)

Shear Stress-Dependent Modulation of Endothelin B Receptor: The Role of Endothelial Glycocalyx Heparan Sulfate
by: Camden Holm, et al.
Published: (2025-07-01)

Hereditary features of plasma concentrations of endothelin-1 in men with hypertension and chronic heart failure
by: H. O. Palahniuk, et al.
Published: (2016-12-01)

Elucidating essential kinases of endothelin signalling by logic modelling of phosphoproteomics data
by: Alexander Schäfer, et al.
Published: (2019-08-01)

The extracellular matrix protein type I collagen and fibronectin are regulated by β-arrestin-1/endothelin axis in human ovarian fibroblasts
by: Ilenia Masi, et al.
Published: (2025-02-01)

HJP 272, an endothelin receptor antagonist, and its role in cancer cell migration and invasion
by: Nabeela Baig, et al.
Published: (2025-10-01)

Endothelin Level and Its Correlation with Uric Acid in Type 2 Diabetic Multiuse Patients
by: Zahraa Majid Ismail, et al.
Published: (2020-08-01)

INHERITANCE OF POLYMORPHIC GENOTYPES OF THE ENDOTHELIN-1 GENE AND INDICATORS OF CARDIAC AND SYSTEMIC HEMODYNAMICS IN MEN WITH ESSENTIAL HYPERTENSION, RESIDENTS OF PODILLYA
by: H.O. Palahniuk, et al.
Published: (2017-03-01)

Expression of endothelin in experimental myocardial infarction in a changed concentration of FGF and VEGF
by: M. G. Shurygin, et al.
Published: (2013-02-01)

The Effects of Exercise in Hypoxia and Normoxia Conditions on Endothelin-1 and EPO in Endurance Runners
by: Roohollah Mohammadi Mirzaei
Published: (2020-07-01)

ENDOTHELINES AND CARDIOVASCULAR PATHOLOGY
by: A. M. Alieva, et al.
Published: (2014-11-01)

Effect of Curcumin on Nitric Oxide and Endothelin-1 Levels in L-NAME-Induced Preeclamptic Wistar Rat
by: Bambang Rahardjo, et al.
Published: (2024-12-01)

Endothelin-1 level in the tear fluid of children with primary congenital glaucoma
by: L. A. Katargina, et al.
Published: (2023-03-01)

AMBRISENTAN: THE POSSIBILITY OF THE TREATMENT FOR PULMONARY ARTERIAL HYPERTENSION WITH THE SELECTIVE BLOCKADE OF THE ENDOTHELIN SYSTEM
by: T. V. Martynuk, et al.
Published: (2014-03-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

Evaluation of the serum levels of endothelin-1 and lipid profile in chronic periodontitis patients, before and after periodontal therapy
by: Vanathy Desingu, et al.
Published: (2024-11-01)

EXPERIENCE OF USING THE NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
by: M. A. Simakova, et al.
Published: (2018-04-01)

A new marker for ventricular tachyarrhythmias in patients with postinfarction left ventricular aneurysm: Big endothelin-1
by: Tufan Çınar, et al.
Published: (2020-02-01)

ELEVATED CIRCULATING ENDOTHELIN-1 AND OXIDATIVE STRESS AS POTENTIAL BIOMARKERS FOR PREECLAMPSIA IN WOMEN FROM TAMILNADU: A CASE CONTROL STUDY.
by: Dr. P. Bagavathiammal, et al.
Published: (2025-03-01)

Estimation of Endothelin-1 and Vitamin D Levels in Patients with Some Renal disease
by: Ihsan Maher Abdul Amir, et al.
Published: (2019-12-01)

Effect of 8 Weeks of Aerobic Training Combined with Vitamin D Supplementation on Nitric Oxide and Endothelin- 1 in Patients with Hypertension
by: Mozaffar Jan faza, et al.
Published: (2023-05-01)

Predicting value of leptin and endothelin-1 toward to unfavorable cardiovascular remodelling in patients with arterial hypertension and metabolic syntrome
by: Yu. A. Miloslavskaya
Published: (2012-08-01)

Association of Endothelin-I and A symmetric Dimethylarginine Levels with Insulin Resistance in Type-2 Diabetes Mellitus Patients
by: Sara Muhammed Khidhir, et al.
Published: (2022-02-01)

The Relation between Endothelial Monocyte-activating Polypeptide II and Polymorphism of Endothelin-1 Gene (G8002A) and Their Effect on Renal Function in Adolescent Patients with Beta-thalassemia Major
by: Dahlia N. Al-Saidi, et al.
Published: (2025-01-01)

NITRIC OXIDE AND ENDOTHELIN-1 IN CHILDREN WITH DIGESTIVE DISORDERS
by: I. V. Panova, et al.
Published: (2012-09-01)

Endothelin-1- and acetylcholine-mediated effects in human and rat vessels: impact of perivascular adipose tissue, diabetes, angiotensin II, and chemerin
by: Edwyn O. Cruz-López, et al.
Published: (2024-12-01)

Endothelin receptor antagonists target EDNRB and modulate the progression of idiopathic pulmonary fibrosis via anoikis-related genes
by: Pengfei Ning, et al.
Published: (2025-06-01)

Assessment of infusion therapy impact on the dynamics of endothelin-1 in patients with acute ischemic stroke
by: A. I. Semenenko, et al.
Published: (2019-02-01)

Increased aqueous humor levels of endothelin-1 in patients with open angle glaucoma
by: Adam Hedberg-Buenz, et al.
Published: (2025-01-01)

Parallels of structural-functional parameters the myocardium, C-type natriuretic peptide and endothelin-1 plasma concentrations in women with uncomplicated essential hypertension
by: V. V. Petrovska, et al.
Published: (2014-12-01)

Lead acetate deteriorates the improvement effect of L-arginine and tetrahydrobiopterin on endothelin-1 receptors activity in rat aorta
by: Zhikal Omar Khudhur, et al.
Published: (2023-10-01)

Tetramethylpyrazine attenuates the blood-brain barrier damage against ischemic stroke by targeting endothelin-1/Akt pathway in astrocytes
by: Minzhen Deng, et al.
Published: (2025-05-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

Research trends and performance of endothelin A receptor antagonist in kidney care: a bibliometric analysis
by: Wisit Cheungpasitporn, et al.
Published: (2025-12-01)